Epigenomics Raises $44.2M in Financing

Epigenomics plans to use the financing to support current operations; build and strengthen marketing, sales, and distribution for its products; and support ongoing and new product development for in the areas of cancer screening, diagnosis, disease progression, and recurrence monitoring.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.